Zymeworks Inc. (NYSE:ZYME)
Market Cap | 611.13M |
---|---|
Revenue | 31.62M |
Gross Profit | 31.62M |
Shares Out | 63M |
EPS (ttm) | -4.06 |
PE Ratio | -2.5789 |
Forward PE | 0.0000 |
Dividend Rate (ttm) | 0.0000 |
Dividend Yield | 0.0000 |
Trading Day | Feb 7 |
---|---|
Last Price | $9.70 |
Previous Close | $9.82 |
Change ($) | -0.12 |
Change (%) | -1.22% |
Day's Open | 9.8 |
Day's Range | Market Closed |
Day's Volume | 484.43K |
52 Week Range | 4.11 - 10.8 |
About Zymeworks Inc.
Zymeworks is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. Zymeworks' suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates.
Zymeworks' lead clinical candidate, zanidatamab (ZW25), is a novel Azymetric™ bispecific antibody which has been granted Breakthrough Therapy designation by the FDA and is currently enrolling in a pivotal clinical trial for refractory HER2-amplified biliary tract cancer (HERIZON-BTC-01) as well as several Phase 2 clinical trials for HER2-expressing gastroesophageal and breast cancers. Zymeworks' second clinical candidate, ZW49, is a novel bispecific HER2-targeting antibody-drug conjugate currently in Phase 1 clinical development and combines the unique design and antibody framework of zanidatamab with Zymeworks' proprietary ZymeLink™ linker and cytotoxin.
Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged through strategic partnerships with nine biopharmaceutical companies.
News
Quick info
Vancouver
British Columbia
V6H 3V9
Zymeworks Inc. income statements (2022) (USD)
August 2022 | August 2022 | May 2022 | February 2022 | |
---|---|---|---|---|
Total Revenue | 5.44M | 5.44M | 1.92M | 19.87M |
Cost of Revenue | 0 | 0 | 0 | 0 |
Gross Profit | 5.44M | 5.44M | 1.92M | 19.87M |
Research & Development | 56.02M | 56.02M | 62.51M | 54.87M |
Selling General & Admin | 15.24M | 15.24M | 12.09M | 5.85M |
Operating Expense | 71.27M | 71.27M | 74.60M | 60.72M |
Operating Income | -65.82M | -65.82M | -72.69M | -40.85M |
Other Income Expense Net | 0 | 0 | 0 | 0 |
EBIT | -65.82M | -65.82M | -72.69M | -40.85M |
Interest Income | -436K | -436K | -302K | -296K |
Pretax Income | -64.63M | -64.63M | -72.7M | -40.52M |
Income Tax | -9K | -9K | -74K | -1.37M |
Minority Interest | 0 | 0 | 0 | 0 |
Net Income | -64.62M | -64.62M | -72.63M | -39.15M |
Net Income Basic | -64.62M | -64.62M | -72.63M | -39.15M |
Zymeworks Inc. income statements (2021) (USD)
November 2021 | August 2021 | May 2021 | February 2021 | |
---|---|---|---|---|
Total Revenue | 4.40M | 1.77M | 644K | 15.68M |
Cost of Revenue | 0 | 0 | 0 | 0 |
Gross Profit | 4.40M | 1.77M | 644K | 15.68M |
Research & Development | 49.89M | 50.71M | 44.28M | 39.26M |
Selling General & Admin | 15.47M | 19.95M | 1.30M | 13.97M |
Operating Expense | 65.36M | 70.66M | 45.58M | 53.23M |
Operating Income | -60.96M | -68.89M | -44.94M | -37.55M |
Other Income Expense Net | 0 | 0 | 0 | 0 |
EBIT | -60.96M | -68.89M | -44.94M | -37.55M |
Interest Income | -340K | -588K | -741K | -1.02M |
Pretax Income | -59.82M | -67.96M | -44.07M | -37.73M |
Income Tax | 764K | -434K | 525K | 161K |
Minority Interest | 0 | 0 | 0 | 0 |
Net Income | -60.58M | -67.52M | -44.59M | -37.89M |
Net Income Basic | -60.58M | -67.52M | -44.59M | -37.89M |
Zymeworks Inc. income statements (2020) (USD)
November 2020 | June 2020 | June 2020 | March 2020 | March 2020 | |
---|---|---|---|---|---|
Total Revenue | 2.64M | N.A | N.A | N.A | N.A |
Cost of Revenue | 0 | N.A | N.A | N.A | N.A |
Gross Profit | 2.64M | N.A | N.A | N.A | N.A |
Research & Development | 53.53M | 39.22M | 39.22M | 36.53M | 36.53M |
Selling General & Admin | 22.81M | 11.23M | 11.23M | 4.81M | 4.81M |
Operating Expense | 76.34M | N.A | N.A | N.A | N.A |
Operating Income | -73.69M | -40.35M | -40.35M | -35.88M | -35.88M |
Other Income Expense Net | 0 | 1.32M | 1.32M | 5.12M | 5.12M |
EBIT | -73.69M | -40.35M | -40.35M | -35.88M | -35.88M |
Interest Income | -1.3M | N.A | N.A | N.A | N.A |
Pretax Income | -72.61M | -39.03M | -39.03M | -30.76M | -30.76M |
Income Tax | -43K | -64K | -64K | 375K | 375K |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Net Income | -72.56M | -38.96M | -38.96M | -31.14M | -31.14M |
Net Income Basic | -72.56M | -38.96M | -38.96M | -31.14M | -31.14M |
Zymeworks Inc. income statements (2019) (USD)
December 2019 | September 2019 | June 2019 | March 2019 | |
---|---|---|---|---|
Total Revenue | N.A | N.A | N.A | N.A |
Cost of Revenue | N.A | N.A | N.A | N.A |
Gross Profit | N.A | N.A | N.A | N.A |
Research & Development | 45.39M | 29.25M | 23.79M | 17.48M |
Selling General & Admin | 27.74M | 10.51M | 11.18M | 7.54M |
Operating Expense | N.A | N.A | N.A | N.A |
Operating Income | -73.83M | -33.58M | -28.66M | -14.57M |
Other Income Expense Net | 1.09M | 2.20M | 222K | 1.12M |
EBIT | -73.83M | -33.58M | -28.66M | -14.57M |
Interest Income | N.A | 15K | 65K | 3K |
Pretax Income | -72.75M | -31.38M | -28.44M | -13.45M |
Income Tax | -502K | -0.91M | 635K | 193K |
Minority Interest | 0 | 0 | 0 | 0 |
Net Income | -72.24M | -30.48M | -29.08M | -13.64M |
Net Income Basic | -72.24M | -30.48M | -29.08M | -13.64M |
Zymeworks Inc. income statements (2018) (USD)
December 2018 | September 2018 | June 2018 | March 2018 | |
---|---|---|---|---|
Total Revenue | N.A | N.A | N.A | N.A |
Cost of Revenue | N.A | N.A | N.A | N.A |
Gross Profit | N.A | N.A | N.A | N.A |
Research & Development | 14.09M | 14.14M | 15.37M | 13.09M |
Selling General & Admin | 5.16M | 6.43M | 7.89M | 6.35M |
Operating Expense | N.A | N.A | N.A | N.A |
Operating Income | 8.54M | -19.54M | -2.02M | -20.11M |
Other Income Expense Net | 1.08M | 833K | -2.02M | -1.16M |
EBIT | 8.54M | -19.54M | -2.02M | -20.11M |
Interest Income | N.A | 166K | 5K | 8K |
Pretax Income | 9.62M | -18.7M | -4.03M | -21.27M |
Income Tax | 345K | 49K | 1.84M | -65K |
Minority Interest | 0 | 0 | 0 | 0 |
Net Income | 9.27M | -18.75M | -5.87M | -21.2M |
Net Income Basic | 9.27M | -18.75M | -5.87M | -21.2M |
Zymeworks Inc. income statements (2017) (USD)
December 2017 | September 2017 | June 2017 | |
---|---|---|---|
Total Revenue | N.A | N.A | N.A |
Cost of Revenue | N.A | N.A | N.A |
Gross Profit | N.A | N.A | N.A |
Research & Development | 12.02M | 11.53M | 8.29M |
Selling General & Admin | 3.97M | 4.57M | 1.60M |
Operating Expense | N.A | N.A | N.A |
Operating Income | 33.34M | -16.7M | -9.23M |
Other Income Expense Net | -334K | 502K | -1.61M |
EBIT | 33.34M | -16.7M | -9.23M |
Interest Income | 484K | 2K | 339K |
Pretax Income | 33M | -16.2M | -10.84M |
Income Tax | 269K | 50K | 125K |
Minority Interest | 0 | 0 | 0 |
Net Income | 32.73M | -16.25M | -10.97M |
Net Income Basic | 32.73M | -16.25M | -11.49M |
Zymeworks Inc. balance sheet (2022) (USD)
August 2022 | August 2022 | May 2022 | February 2022 | |
---|---|---|---|---|
Current Cash | 241.83M | 241.83M | 300.53M | 252.61M |
Receivables | 4.20M | 4.20M | 4.23M | 15.61M |
Inventory | 0 | 0 | 0 | 0 |
Current Assets | 263.07M | 263.07M | 324.02M | 288.22M |
Other Current Assets | 17.04M | 17.04M | 19.26M | 20M |
Short Term Investments | 17.04M | 17.04M | 19.26M | 20M |
Long Term Investments | 105.90M | 105.90M | 105.96M | 100.91M |
Property/Plant Equipment | 26.16M | 26.16M | 25.75M | 22.78M |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 23.54M | 23.54M | 22.33M | 21.47M |
Tangible Assets (Net) | 186.73M | 186.73M | 248.10M | 215.61M |
Other Assets | 17.37M | 17.37M | 18.73M | 13.70M |
Total Assets | 368.97M | 368.97M | 429.98M | 389.13M |
Accounts Payable | 5.89M | 5.89M | 14.03M | 5.17M |
Other Current Liabilities | 74.20M | 74.20M | 65.95M | 66.68M |
Total Current Liabilities | 80.09M | 80.09M | 79.97M | 71.85M |
Total Liabilities | 146.69M | 146.69M | 147.53M | 140.04M |
Long Term Debt | 113K | 113K | 92K | 100K |
Current Long Term Debt | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 |
Common Stock | 66.35M | 66.35M | 61.37M | 51.55M |
Treasury Stock | 0 | 0 | 0 | 0 |
Retained Earnings | -820.35M | -820.35M | -755.73M | -683.1M |
Capital Surplus | N.A | N.A | N.A | N.A |
Shareholder Equity | 222.28M | 222.28M | 282.44M | 249.09M |
Other Liabilities | N.A | N.A | N.A | N.A |
Zymeworks Inc. balance sheet (2021) (USD)
November 2021 | August 2021 | May 2021 | February 2021 | |
---|---|---|---|---|
Current Cash | 307.76M | 359.81M | 411.47M | 426.35M |
Receivables | 4.93M | 9.16M | 4.58M | 15.29M |
Inventory | 0 | 0 | 0 | 0 |
Current Assets | 336.76M | 392.96M | 432.77M | 455.08M |
Other Current Assets | 24.08M | 23.99M | 16.72M | 13.43M |
Short Term Investments | 24.08M | 23.99M | 16.72M | 13.43M |
Long Term Investments | 83.60M | 79M | 57.29M | 83.30M |
Property/Plant Equipment | 18.56M | 13.97M | 12.31M | 12.19M |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 20.33M | 20.79M | 21.84M | 22.93M |
Tangible Assets (Net) | 246.59M | 288.67M | 343.29M | 374.98M |
Other Assets | 5.24M | 3.07M | 3M | 3.10M |
Total Assets | 420.36M | 471.95M | 490.06M | 538.38M |
Accounts Payable | 5.05M | 4.66M | 4.88M | 6.24M |
Other Current Liabilities | 70.38M | 78.34M | 65.37M | 79.42M |
Total Current Liabilities | 75.43M | 83.01M | 70.25M | 85.67M |
Total Liabilities | 141.43M | 150.48M | 112.91M | 128.45M |
Long Term Debt | 105K | 111K | 114K | 122K |
Current Long Term Debt | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 |
Common Stock | 51.66M | 51.42M | 51.37M | 50.38M |
Treasury Stock | 0 | 0 | 0 | 0 |
Retained Earnings | -643.95M | -583.37M | -515.85M | -471.26M |
Capital Surplus | N.A | N.A | N.A | N.A |
Shareholder Equity | 278.93M | 321.47M | 377.15M | 409.92M |
Other Liabilities | N.A | N.A | N.A | N.A |
Zymeworks Inc. balance sheet (2020) (USD)
November 2020 | June 2020 | March 2020 | |
---|---|---|---|
Current Cash | 471.86M | 219.57M | 189.49M |
Receivables | 3.69M | 14.83M | 8.65M |
Inventory | 0 | N.A | N.A |
Current Assets | 487.32M | 471.30M | 504.61M |
Other Current Assets | 11.77M | 19.68M | 8.29M |
Short Term Investments | 11.77M | 217.22M | 298.18M |
Long Term Investments | 84.40M | 75.98M | 75.76M |
Property/Plant Equipment | 12.52M | 18.13M | 17.35M |
Good Will | N.A | N.A | N.A |
Intangible Assets | 6.40M | 25.12M | 23.52M |
Tangible Assets (Net) | 413.94M | 479.24M | 510.40M |
Other Assets | 20.60M | 2.97M | 2.87M |
Total Assets | 571.72M | 606.85M | 636.58M |
Accounts Payable | 3.13M | 4.74M | 12.45M |
Other Current Liabilities | 93.76M | 66.12M | 58.68M |
Total Current Liabilities | 96.89M | 72.78M | 72.91M |
Total Liabilities | 139.37M | 115.60M | 114.16M |
Long Term Debt | 115K | 6.66M | 7.34M |
Current Long Term Debt | 0 | 29K | 23K |
Minority Interest | 0 | 0 | 0 |
Common Stock | 872.38M | 45.56M | 45.53M |
Treasury Stock | 0 | N.A | N.A |
Retained Earnings | -433.37M | -360.81M | -321.85M |
Capital Surplus | N.A | 150.40M | 143.31M |
Shareholder Equity | 432.35M | 491.25M | 522.42M |
Other Liabilities | N.A | N.A | N.A |
Zymeworks Inc. balance sheet (2019) (USD)
December 2019 | September 2019 | June 2019 | March 2019 | |
---|---|---|---|---|
Current Cash | 128.45M | 250.84M | 283.52M | 43.17M |
Receivables | 2.19M | 3.33M | 2.71M | 703K |
Inventory | N.A | N.A | N.A | N.A |
Current Assets | 311.83M | 345.31M | 366.43M | 190.33M |
Other Current Assets | 10.74M | 6.79M | 7.98M | 8.99M |
Short Term Investments | 170.45M | 84.26M | 72.13M | 137.13M |
Long Term Investments | N.A | N.A | N.A | N.A |
Property/Plant Equipment | 16.50M | 15.59M | 15.74M | 13.95M |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 23.69M | 24.59M | 17.94M | 19.36M |
Tangible Assets (Net) | 187.96M | 297.51M | 322M | 157.99M |
Other Assets | 2.96M | 2.28M | 2.29M | 2.55M |
Total Assets | 368.21M | 400.04M | 414.55M | 238.28M |
Accounts Payable | 5.35M | 8.04M | 4.08M | 1.44M |
Other Current Liabilities | 75.91M | 41.73M | 34.63M | 24.56M |
Total Current Liabilities | 82.55M | 50.69M | 40.39M | 28.16M |
Total Liabilities | 122.52M | 90.51M | 80.53M | 68.27M |
Long Term Debt | 5.65M | 5.89M | 6.21M | 6.45M |
Current Long Term Debt | 10K | 9K | 14K | 13K |
Minority Interest | 0 | 0 | 0 | 0 |
Common Stock | 39.56M | 39.34M | 39.18M | 32.05M |
Treasury Stock | N.A | N.A | N.A | N.A |
Retained Earnings | -290.71M | -218.47M | -187.99M | -158.91M |
Capital Surplus | 92.84M | 90.21M | 87.49M | 14.63M |
Shareholder Equity | 245.68M | 309.53M | 334.02M | 170.01M |
Other Liabilities | N.A | N.A | N.A | N.A |
Zymeworks Inc. balance sheet (2018) (USD)
December 2018 | September 2018 | June 2018 | March 2018 | |
---|---|---|---|---|
Current Cash | 42.21M | 28.38M | 55.38M | 30.98M |
Receivables | 358K | 253K | 303K | 49K |
Inventory | N.A | N.A | N.A | N.A |
Current Assets | 204.37M | 153.80M | 172.26M | 74.42M |
Other Current Assets | 2.85M | 2.54M | 3.81M | 2.42M |
Short Term Investments | 157.96M | 121.63M | 110.85M | 39.05M |
Long Term Investments | N.A | N.A | N.A | N.A |
Property/Plant Equipment | 6.48M | 6.39M | 6.75M | 6.95M |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 20.01M | 20.66M | 18.69M | 18.92M |
Tangible Assets (Net) | 130.33M | 157.65M | 174.45M | 82.51M |
Other Assets | 1.40M | 1.34M | 1.15M | 1.18M |
Total Assets | 244.36M | 194.44M | 211M | 113.54M |
Accounts Payable | 2.60M | 1.22M | 5.62M | 0.96M |
Other Current Liabilities | 27.07M | 22.61M | 18.11M | 17.16M |
Total Current Liabilities | 29.99M | 23.96M | 23.75M | 18.19M |
Total Liabilities | 63.87M | 24.77M | 24.53M | 19.01M |
Long Term Debt | 42K | 46K | 48K | 51K |
Current Long Term Debt | 15K | 16K | 17K | 16K |
Minority Interest | 0 | 0 | 0 | 0 |
Common Stock | 31.98M | 31.96M | 31.95M | 25.46M |
Treasury Stock | N.A | N.A | N.A | N.A |
Retained Earnings | -145.27M | -154.55M | -135.79M | -129.92M |
Capital Surplus | 12.35M | 10.98M | 9.21M | 7.96M |
Shareholder Equity | 180.49M | 169.67M | 186.47M | 94.53M |
Other Liabilities | N.A | N.A | N.A | N.A |
Zymeworks Inc. balance sheet (2017) (USD)
December 2017 | September 2017 | June 2017 | |
---|---|---|---|
Current Cash | 35.95M | 12.33M | 26M |
Receivables | 238K | 180K | 1.43M |
Inventory | N.A | N.A | N.A |
Current Assets | 92.34M | 54.43M | 70.30M |
Other Current Assets | 2.21M | 3.37M | 4.67M |
Short Term Investments | 51.85M | 36.76M | 36.48M |
Long Term Investments | N.A | N.A | N.A |
Property/Plant Equipment | 7.18M | 7.54M | 7.43M |
Good Will | N.A | N.A | N.A |
Intangible Assets | 19.14M | 19.40M | 18.62M |
Tangible Assets (Net) | 68.88M | 70.56M | 84.91M |
Other Assets | 1.22M | 1.25M | 1.28M |
Total Assets | 131.96M | 99.72M | 114.54M |
Accounts Payable | 1.66M | 1.95M | 1.98M |
Other Current Liabilities | 12.83M | 9.87M | 10.44M |
Total Current Liabilities | 14.66M | 11.91M | 12.57M |
Total Liabilities | 15.53M | 17.15M | 17.62M |
Long Term Debt | 52K | N.A | N.A |
Current Long Term Debt | 10K | 10K | 10K |
Minority Interest | 0 | 0 | 0 |
Common Stock | 25.44M | 25.34M | 25.33M |
Treasury Stock | N.A | N.A | N.A |
Retained Earnings | -108.72M | -141.45M | -125.2M |
Capital Surplus | 8.81M | 8.52M | 6.49M |
Shareholder Equity | 116.43M | 82.58M | 96.93M |
Other Liabilities | N.A | N.A | N.A |
Zymeworks Inc. cash flow (2022) (USD)
August 2022 | |
---|---|
Net Income | -64.62M |
Depreciation | 2.17M |
Changes in Receivables | 4.20M |
Changes in Inventories | 0 |
Cash Change | 241.83M |
Cash Flow | -54.82M |
Capital Expenditures | -3.75M |
Investments | N.A |
Investing Activity (other) | N.A |
Total Investing Cash Flows | -21.93M |
Dividends Paid | N.A |
Net Borrowings | -258.76M |
Other Financing Cash Flows | N.A |
Cash Flow Financing | -279K |
Exchange Rate Effect | N.A |
Zymeworks Inc. cash flow (2021) (USD)
November 2021 | |
---|---|
Net Income | -60.58M |
Depreciation | 2.76M |
Changes in Receivables | 4.93M |
Changes in Inventories | 0 |
Cash Change | 307.76M |
Cash Flow | -50.79M |
Capital Expenditures | -5.21M |
Investments | N.A |
Investing Activity (other) | N.A |
Total Investing Cash Flows | 250.54M |
Dividends Paid | N.A |
Net Borrowings | -331.73M |
Other Financing Cash Flows | N.A |
Cash Flow Financing | 4.55M |
Exchange Rate Effect | N.A |
Zymeworks Inc. cash flow (2020) (USD)
November 2020 | June 2020 | March 2020 | |
---|---|---|---|
Net Income | -72.56M | -38.96M | -31.14M |
Depreciation | 5.50M | 2.19M | 2.82M |
Changes in Receivables | -11.13M | -6.17M | -6.47M |
Changes in Inventories | 0 | N.A | N.A |
Cash Change | 35.07M | 28.76M | 61.03M |
Cash Flow | -103.5M | -48.26M | -37.74M |
Capital Expenditures | -3.29M | -1.62M | -0.95M |
Investments | N.A | 83.78M | -203.82M |
Investing Activity (other) | N.A | N.A | N.A |
Total Investing Cash Flows | -86.84M | 82.16M | -204.77M |
Dividends Paid | N.A | N.A | N.A |
Net Borrowings | -483.51M | -422.42K | 248K |
Other Financing Cash Flows | N.A | -138.83K | 60K |
Cash Flow Financing | 306.28M | -4.63M | 303.08M |
Exchange Rate Effect | N.A | -509.27K | 460K |
Zymeworks Inc. cash flow (2019) (USD)
December 2019 | September 2019 | June 2019 | March 2019 | |
---|---|---|---|---|
Net Income | -72.24M | -30.48M | -29.08M | -13.64M |
Depreciation | 2.59M | 1.73M | 1.58M | 1.48M |
Changes in Receivables | 1.14M | -616K | -2.01M | -345K |
Changes in Inventories | N.A | N.A | N.A | N.A |
Cash Change | -123.52M | -30.33M | 239.58M | 0.97M |
Cash Flow | -35.68M | -11.82M | -12.68M | -21.3M |
Capital Expenditures | -2.11M | -10.37M | -1.37M | -31K |
Investments | -86.62M | -11.66M | 64.47M | 22.04M |
Investing Activity (other) | N.A | N.A | N.A | N.A |
Total Investing Cash Flows | -88.8M | -22.03M | 63.10M | 22.01M |
Dividends Paid | N.A | N.A | N.A | N.A |
Net Borrowings | -756.59K | 482.88K | -537.29K | N.A |
Other Financing Cash Flows | -653.39K | N.A | 26K | -26K |
Cash Flow Financing | 0.96M | 3.54M | 188.80M | 569K |
Exchange Rate Effect | -71 | -20.61K | 353.84K | -303K |
Zymeworks Inc. cash flow (2018) (USD)
December 2018 | September 2018 | June 2018 | March 2018 | |
---|---|---|---|---|
Net Income | 9.27M | -18.75M | -5.87M | -21.2M |
Depreciation | 1.11M | 0.99M | 744.15K | 719K |
Changes in Receivables | -105K | 50K | -254K | 189K |
Changes in Inventories | N.A | N.A | N.A | N.A |
Cash Change | 13.60M | -26.69M | 24.20M | -4.97M |
Cash Flow | 49.26M | -12.55M | 4.59M | -17.57M |
Capital Expenditures | -317.54K | -2.55M | -388.38K | -165K |
Investments | -34.86M | -10.23M | -71.28M | 12.70M |
Investing Activity (other) | N.A | N.A | N.A | N.A |
Total Investing Cash Flows | -35.12M | -12.78M | -71.66M | 12.54M |
Dividends Paid | N.A | N.A | N.A | N.A |
Net Borrowings | -3.12K | -2.93K | -1.95K | -3K |
Other Financing Cash Flows | -220.83K | N.A | N.A | N.A |
Cash Flow Financing | -430.7K | -1.39M | 91.42M | 131K |
Exchange Rate Effect | -112.28K | 21.80K | -146.9K | -60K |
Zymeworks Inc. cash flow (2017) (USD)
December 2017 | September 2017 | June 2017 | |
---|---|---|---|
Net Income | 32.73M | -16.25M | -10.97M |
Depreciation | 713.25K | 817.38K | 677.95K |
Changes in Receivables | -58K | 1.25M | -0.96M |
Changes in Inventories | N.A | N.A | N.A |
Cash Change | 24.21M | -13.78M | 15.48M |
Cash Flow | 40.76M | -14.1M | -13.74M |
Capital Expenditures | -284.37K | -1.4M | -517.62K |
Investments | -15.14M | -787.21K | -7.51M |
Investing Activity (other) | N.A | N.A | N.A |
Total Investing Cash Flows | -15.49M | -2.19M | -20.45M |
Dividends Paid | N.A | N.A | N.A |
Net Borrowings | 348.38K | -414.94K | -7.75M |
Other Financing Cash Flows | N.A | N.A | N.A |
Cash Flow Financing | -1.06M | 2.46M | 49.61M |
Exchange Rate Effect | -5.4K | 48.67K | 56.50K |
Zymeworks Inc. dividends (USD)
Total Valuation
Zymeworks BC Inc has a market cap or net worth of $611.13 million. The enterprise value is $369.41 million.
Important Dates
Share Statistics
Zymeworks BC Inc has 63 million shares outstanding.
Valuation Ratios
The trailing PE ratio is -2.5789 and the forward PE ratio is 0.0000. Zymeworks BC Inc's PEG ratio is -0.3919.
Stock Price Statistics
The stock price has increased by 0.2341%. The beta is 0.9505, so Zymeworks BC Inc's price volatility has been lower than the market average.
Income Statement
In the last 12 months, Zymeworks BC Inc had revenue of $31.62 million and earned $31.62 million in profits. Earnings per share was $-4.06.